The impact of <i>MEIS1</i> TALE homeodomain transcription factor knockdown on glioma stem cell growth-Reference-Cited by-同舟云学术

The impact of MEIS1 TALE homeodomain transcription factor knockdown on glioma stem cell growth

Published:2024-03-13 Issue:1 Volume:28 Page:93-109
ISSN:1976-8354
Container-title:Animal Cells and Systems
language:en
Short-container-title:Animal Cells and Systems

Author:

Kim Hyun-Jin¹,Batara Don Carlo¹^ORCID,Jeon Young-Jun²,Lee Seongsoo³⁴,Beck Samuel⁵,Kim Sung-Hak¹

Affiliation:

1. Animal Molecular Biochemistry Laboratory, Department of Animal Science, College of Agriculture and Life Sciences, Chonnam National University, Gwangju, Republic of Korea

2. Department of Integrative Biotechnology, Sungkyunkwan University, Suwon-si, Gyeonggi-do, Republic of Korea

3. Gwangju Center, Korea Basic Science Institute (KBSI), Gwangju, Republic of Korea

4. Department of Systems Biotechnology, Chung-Ang University, Anseong-si, Gyeonggi-do, Republic of Korea

5. Department of Dermatology, Center for Aging Research, Chobanian & Avedisian School of Medicine, Boston University, Boston, USA

Funder

National Institutes of Health

Basic Science Research Program of the National Research Foundation of Korea

Ministry of Education, Science, and Technology

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/19768354.2024.2327340

Reference62 articles.

1. Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target

2. User's guide to correlation coefficients

3. Role of glioblastoma stem cells in cancer therapeutic resistance: a perspective on antineoplastic agents from natural sources and chemical derivatives

4. HOX and PBX gene dysregulation as a therapeutic target in glioblastoma multiforme

5. Epigenetic inactivation of the Sotos overgrowth syndrome gene histone methyltransferase NSD1 in human neuroblastoma and glioma